HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
José Manuel Trigo Selected Research
José Manuel Trigo Research Topics
Disease
6
Disease Progression
10/2023 - 02/2008
6
Neoplasms (Cancer)
01/2022 - 02/2008
3
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 01/2014
3
Renal Cell Carcinoma (Grawitz Tumor)
04/2010 - 03/2008
2
Small Cell Lung Carcinoma (Small Cell Lung Cancer)
10/2023 - 06/2022
2
Neoplasm Metastasis (Metastasis)
01/2014 - 03/2009
1
Constipation
10/2023
1
Fatigue
10/2023
1
Vomiting
10/2023
1
Ovarian Neoplasms (Ovarian Cancer)
10/2023
1
Nausea
10/2023
1
Melanoma (Melanoma, Malignant)
01/2022
1
Colorectal Neoplasms (Colorectal Cancer)
01/2022
1
Microsatellite Instability
01/2022
1
Thyroid Neoplasms (Thyroid Cancer)
10/2017
1
medullary Thyroid cancer
10/2017
1
Breast Neoplasms (Breast Cancer)
09/2017
1
Pneumonia (Pneumonitis)
01/2014
1
Lung Neoplasms (Lung Cancer)
01/2014
1
Liver Diseases (Liver Disease)
11/2012
1
Cachexia
06/2011
1
Brain Neoplasms (Brain Tumor)
06/2011
1
Pulmonary Embolism
06/2011
1
Anorexia
06/2011
1
Sepsis (Septicemia)
06/2011
1
Leukoencephalopathies
06/2011
1
Cardiotoxicity
06/2011
1
Delirium
06/2011
1
Aggressive Fibromatosis (Desmoid)
03/2011
1
Adenomatous Polyposis Coli (Familial Adenomatous Polyposis)
03/2011
1
Tobacco Use Disorder (Nicotine Dependence)
11/2010
1
Substance-Related Disorders (Drug Abuse)
05/2010
1
Brain Diseases (Brain Disorder)
05/2010
1
Kidney Neoplasms (Kidney Cancer)
03/2008
1
Hypoxia (Hypoxemia)
03/2008
1
Seizures (Absence Seizure)
08/2005
Drug/Important Bio-Agent (IBA)
3
Tyrosine Kinase Inhibitors
IBA
01/2021 - 02/2012
2
Platinum
IBA
10/2023 - 08/2012
2
Immune Checkpoint Inhibitors
IBA
06/2022 - 01/2022
2
Monoclonal Antibodies
IBA
01/2022 - 11/2012
2
Opioid Analgesics (Opioids)
IBA
11/2010 - 05/2010
1
PM 01183
IBA
10/2023
1
Alanine Transaminase (SGPT)
IBA
10/2023
1
Transaminases (Aminotransferases)
IBA
10/2023
1
Aspartate Aminotransferases (Aspartate Transaminase)
IBA
10/2023
1
Ligands
IBA
01/2022
1
triplex DNA (H-DNA)
IBA
01/2022
1
ErbB Receptors (EGF Receptor)
IBA
01/2021
1
Iodine
IBA
10/2017
1
Axitinib (AG 013736)
IBA
10/2017
1
src-Family Kinases
IBA
09/2017
1
Trastuzumab (Herceptin)
FDA Link
09/2017
1
Dasatinib (BMS 354825)
FDA Link
09/2017
1
Paclitaxel (Taxol)
FDA Link
Generic
09/2017
1
L-BLP25
IBA
01/2014
1
Lipopeptides
IBA
01/2014
1
Antigens
IBA
01/2014
1
Cisplatin (Platino)
FDA Link
Generic
08/2012
1
Albumins
IBA
06/2011
1
Contraceptive Agents (Contraceptives)
IBA
03/2011
1
Neurotransmitter Agents (Neurotransmitter)
IBA
05/2010
1
Gemcitabine
FDA Link
04/2010
1
Capecitabine (Xeloda)
FDA Link
04/2010
1
Sorafenib (BAY 43-9006)
FDA Link
04/2010
1
Interferon-alpha (Interferon Alfa)
IBA
03/2009
1
Interleukin-2 (IL2)
IBA
03/2009
1
Sunitinib (Sutent)
FDA Link
03/2008
1
Transcription Factors (Transcription Factor)
IBA
03/2008
1
Platelet-Derived Growth Factor
IBA
03/2008
1
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
03/2008
1
Depsipeptides
IBA
02/2008
1
kahalalide F
IBA
02/2008
1
Cocaine (Cocaine HCl)
IBA
08/2005
Therapy/Procedure
7
Therapeutics
10/2017 - 03/2008
5
Drug Therapy (Chemotherapy)
10/2023 - 06/2011
1
Immunotherapy
01/2014
1
Injections
01/2014
1
Chemoradiotherapy
01/2014
1
Adjuvant Radiotherapy
03/2011
1
Combined Modality Therapy
03/2011
1
Radiotherapy
03/2009